Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole

Gastrointestinal Endoscopy

Volumn 60, Issue 2, 2004, Pages 213-217

  Lee, Sun Young ^a   Kim, Jae J ^a,b   Haeng Lee, Jun ^a   Kim, Young Ho ^a   Rhee, Poong Lyul ^a   Woon Paik, Seung ^a   Chul Rhee, Jong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SCREENING; EPIGASTRIC PAIN; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMACH ULCER; ULCER HEALING;

ADENOMA; AGED; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; STOMACH ULCER; TIME FACTORS; WOUND HEALING;

EID: 3242794155     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(04)01683-9     Document Type: Article

References (21)

1. Inoue H. Treatment of esophageal and gastric tumors. Endoscopy. 33:2001;119-125
2. Hashimoto T., Adachii K. Changes in gastric mucosal blood flow during healing of EMR-induced ulcer: comparison with peptic ulcer. Dig Endosc. 9:1997;127-131
3. Hashimoto T., Adachii K., Fukumoto S. Changes of gastric mucosal blood flow during the healing process of artificial ulcer caused by endoscopic mucosal resection. [Japanese with English abstract] Gastroenterol Endosc. 7:1995;554-560
4. Tarnawski A., Stachura J., Durbin T., Sarfeh I., Gergely H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology. 102:1992;695-698
5. Kobayashi K., Arakawa T., Nakamura H., Chono S., Yamada H., Satoh H., et al. Protective action of endogenous prostacyclin (PGI2) and prostaglandin E2 (PGE2) in endoscopic polypectomy induced human ulcers. Gastroenterol Jpn. 17:1982;430-433
6. Muller P., Dammann H.G., Leucht U., Simon B. Human gastric acid secretion following repeated doses of AG-1749. Aliment Pharmacol Ther. 3:1989;193-198
7. Bardhan K.D., Ahlberg J., Hislop W.S., Lindholmer C., Long R.G., Morgan A.G., et al. Rapid healing of gastric ulcers with lansoprazole. Aliment Phamacol Ther. 8:1994;215-220
8. Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy. 17:1997;22-37
9. Esaki M., Aoyagi K., Matsumoto T., Kuwano Y., Shimizu M., Fujishima M. Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. Eur J Gastroenterol Hepatol. 14:2002;365-369
10. Ono H., Kondo H., Gotoda T., Shirao K., Yamaguchi H., Saito D., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 48:2001;225-229
11. Sakita T., Fukutomi H. Endoscopic diagnosis. Yoshitoshi Y. Ulcer of stomach and duodenum [Japanese]. 1971;198-208 Nankodo, Tokyo
12. Chow S.C., Liu J.P. Design and analysis of clinical trials: concepts and methodologies. 1998;John Wiley and Sons, New York. p. 434
13. Panes J., Casadevall M., Pique J.M., Bosch J., Whilttle B.J., Teres J. Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: roles of nitric oxide. Gastroenterology. 103:1992;407-413
14. Tepperman B.L., Soper B.D. Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat. Regul Pept. 50:1994;13-21
15. Hui W.M., Chen B.W., Kung A.W., Cho C.H., Luk C.T., Lam S.K. Effect of epidermal growth factor on gastric blood flow in rats; possible role in mucosal protection. Gastroenterology. 104:1993;1605-1610
16. Aoyama N., Kinoshita Y., Misaki F., Himeno S., Kasuga M., Chiba T. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter. J Clin Gastroenterol. 20:(Suppl 2):1995;S86-S89
17. Adachi K., Suetsugu H., Moriyama N., Kazumori H., Kawamura A., Fujishiro H., et al. Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection induced ulcers. J Gastroenterol Hepatol. 16:2001;1211-1216
18. Graham D.Y., Lew G.M., Klein P.D., Evans D.G., Evans D.J. Jr., Saeed Z.A., et al. Effect of treatment of Helicobacter pylori infection on long term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med. 116:1992;705-708
19. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69
20. Suzuki M., Suzuki H., Kitahora T., Miyazawa M., Nagahashi S., Suzuki K., et al. Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. Aliment Pharmacol Ther. 16:(Suppl 2):2002;229-234
21. Tatsuta M., Ishikawa H., Iishi H., Okuda S., Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut. 31:1990;973-976